Monica Corada

Author PubWeight™ 36.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 2007 4.10
2 Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 2008 3.22
3 Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 2003 2.92
4 EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 2013 2.70
5 Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 2005 2.45
6 VE-cadherin regulates endothelial actin activating Rac and increasing membrane association of Tiam. Mol Biol Cell 2002 1.97
7 VE-cadherin is not required for the formation of nascent blood vessels but acts to prevent their disassembly. Blood 2004 1.81
8 Phosphorylation of VE-cadherin is modulated by haemodynamic forces and contributes to the regulation of vascular permeability in vivo. Nat Commun 2012 1.78
9 JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. Blood 2007 1.47
10 Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. J Clin Invest 2004 1.47
11 Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis. Blood 2003 1.23
12 VE-cadherin is a critical endothelial regulator of TGF-beta signalling. EMBO J 2008 1.22
13 Vascular endothelial growth factor induces SHC association with vascular endothelial cadherin: a potential feedback mechanism to control vascular endothelial growth factor receptor-2 signaling. Arterioscler Thromb Vasc Biol 2002 1.14
14 JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling. J Cell Sci 2009 1.12
15 Junctional adhesion molecule-A deficiency increases hepatic ischemia-reperfusion injury despite reduction of neutrophil transendothelial migration. Blood 2005 1.04
16 VE-cadherin expression and clustering maintain low levels of survivin in endothelial cells. Am J Pathol 2004 1.03
17 Downregulation of vascular endothelial-cadherin expression is associated with an increase in vascular tumor growth and hemorrhagic complications. Thromb Haemost 2005 0.99
18 Wnt activation of immortalized brain endothelial cells as a tool for generating a standardized model of the blood brain barrier in vitro. PLoS One 2013 0.98
19 Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells. Blood 2012 0.94
20 Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler Thromb Vasc Biol 2005 0.93
21 The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? Pharmacol Res 2010 0.91
22 Abrogation of junctional adhesion molecule-A expression induces cell apoptosis and reduces breast cancer progression. PLoS One 2011 0.86
23 Inactivation of junctional adhesion molecule-A enhances antitumoral immune response by promoting dendritic cell and T lymphocyte infiltration. Cancer Res 2010 0.84
24 Targeting endothelial junctional adhesion molecule-A/ EPAC/ Rap-1 axis as a novel strategy to increase stem cell engraftment in dystrophic muscles. EMBO Mol Med 2013 0.81